Please RT: Opportunity to join us as technician! We are looking for a technician to support us in our projects in MPN and other myeloid malignancies using epigenomics on primary samples and PDX mouse models. Where: @carrerasijc.bsky.social When: Anytime. What: 👉https://sl1nk.com/0ekf3z6

MEET THE LAB! Paula, Jeannine, Marina and Marcus are in Finland attending the @EHA_Hematology Research Conference #EHAReCon2026 "From cradle to grave: normal and malignant hematopoiesis in young and aged settings". For our presentations, come and check out Poster 44 & Poster 68!

Great opportunity for Senescence aficionados to share results and network in Spain's most beautiful university town!

Florencia Herbstein@florherbstein.bsky.social · 5mo ago

Two opportunities across two continents to connect with the cellular senescence community in 2026 🌍! Excited to be part of the organizing team for the @yicsac.bsky.social #Salamanca Symposium. See you there! #senescence #EarlyCareerResearchers

Check out the new profile page of the lab on LinkedIN! We will post news about: - Changes in the team composition - Opportunities - Where to meet us - Preprints, publications and theses Indeed, we have been growing. Find out more here: www.linkedin.com/company/busc...

Buschbeck Lab | LinkedIn

Buschbeck Lab | 50 followers on LinkedIn. We combine basic and applied research in chromatin and metabolism in myeloid malignancies. | We combine basic research and applied research. In our basic rese...

linkedin.com

As 2025 comes to a close, my university (Dalhousie U in Halifax, Canada) is recruiting faculty, including outstanding early career researchers, and Canada Research Chairs. Applications are due January 19 2026 (was just notified today!). Please repost.

Dalhousie University is recruiting up to 30 tenure and tenure-track faculty positions

Backed by the Government of Canada’s $1.7 billion Global Impact+ Research Talent Initiative, Dalhousie University is undertaking one of the most ambitious research-leader recruitment efforts in its hi...

dal.ca

Ten days left to apply to be a @crick.ac.uk Early Career Group Leader Closing date 27th November www.crick.ac.uk/careers-stud...

Early career group leaders

We appoint researchers from across biology and biomedicine to set up their first groups at the Crick.

crick.ac.uk

James Briscoe@jamesbriscoe.bsky.social · 10mo ago

The @crick.ac.uk is recruiting Early Career Group Leaders - Lab set-up, research costs, salaries for up to 5 researchers - Support for up to 12 years - Access to our core facilities - Competitive salary - Fantastic colleagues - All areas of biology Deadline 27 Nov www.crick.ac.uk/careers-stud...

Last opportunity to join the NUCLEAR network as PhD student in a Biotech environment!

NUCLEAR-DN@nucleardn.bsky.social · 9mo ago

📢 Last chance to join the NUCLEAR project! Eisbach Bio GmbH is seeking a motivated PhD student to study NAD+ modulation of PARP1/2 in cancer research. Deadline application: November 27. Apply here: www.eisbach.bio#175327907442...

Last opportunity to join the NUCLEAR network as PhD student!

NUCLEAR-DN@nucleardn.bsky.social · 9mo ago

🚀 PhD Opportunity in the NUCLEAR Doctoral Network! 🎓 Eligibility: Applicants must meet the MSCA mobility rule. 📩 Deadline 11 Dec. Apply here: lnkd.in/eKM8JKeE 🔗 Learn more about our lab: www.rodriguezcolmanlab.org Please share within your networks! 🌍🧬

OFERTA DE EMPLEO (por favor difundir): Ofrecemos un contrato predoctoral de 4 años asociado a nuestro proyecto PID2024-157249OB-I00. El objetivo del proyecto es evaluar un nuevo mecanismo patológico según el cual la competición entre promotores puede llegar a ocasionar enfermedades congénitas 👇

NEW PAPER Out in Science Advances: We have dissected the physiological role of all macroH2A histone variants. In mice, loss of macroH2A1.1 specifically results in profound metabolic reprogramming and kidney pathology. DOI: 10.1126/sciadv.adz1242 Thread 1/7

True in 9 out of 10 cases.

Cristina Muñoz Pinedo@crismunozp.bsky.social · 10mo ago

We (scientists) think we are smart, but we are unable to get past this screen at editorialmanager.com

MEET THE LAB! This week our postdoc René Winkler will attend the @febspress.bsky.social workshop 'Molecular and cellular pathways of aging in hematopoiesis' on Crete, Greece. René will present work led by @shubhra.bsky.social on how cohesin mutations impact MDS progression.

MEET THE LAB Today Marina Farkas is attending the "Molecular Haemopoiesis" meeting at the Francis Crick Institute in London, UK. A gathering of researchers studying #blood development, with a particular focus on blood stem cell biology, gene regulation and #leukaemia.

We are recuiting two new Associate Professors here in Oxford Biochemistry. Come join us! Reach out to me if you have any questions. Please repost! tinyurl.com/mr3m7bd3

Adios and salut to a pioneer! Sir John Gurdon studied the requirements and barriers of #reprogramming. Highly relevant for us, with his PhD student Vincent Pasque he showed that macroH2A is part of the epigenetic barrier inhibiting reprogramming. Our thoughts are with his family and friends.

Manuel Collado@manuel-collado.bsky.social · 10mo ago

Sad to hear about the passing of John Gurdon, a titan and pioneer of developmental biology and much more. Winner of the Nobel Prize in Medicine or Physiology, shared with Shinya Yamanaka, who actually was inspired by his work www.cam.ac.uk/research/new...

NEW TEAM MEMBER! We welcome Bedri Batuhan Yaman to the group. Bedri will study the role of nuclear metabolism in #AML. He is co-supervised by @florherbstein.bsky.social and fellow of the MSCA @nucleardn.bsky.social. Bedri is alumnus of @viblifesciences.bsky.social (Belgium) and NeuroBM (Turkey).

Looking for scientists working with long-read transcriptomics technologies to join a COST action proposal. Contact us!!! @nanoporetech.com @pacbio.bsky.social

We have a new PhD studentship in the lab on the immunogenic roles of transposable elements in paediatric acute myeloid leukaemia! Come and work with us! www.colcc.ac.uk/2026-cyp-phd...

2026 CYP PhD Project Deniz

Uncovering the Immunogenic Landscape of Transposon-Driven Transcripts in Paediatric Acute Myeloid Leukaemia Primary supervisor: Özgen Deniz, Queen Mary University of London Secondary supervisor: Ri...

colcc.ac.uk

Cancer Research UK City of London Centre@cruk-cityoflondon.bsky.social · 10mo ago

Are you interested in doing a #PhD in #cancerresearch? 🧪🧑‍🔬👨🏽‍🔬👩🏿‍🔬🧫🦠🔬 Do you want to develop new #biotherapeutics? Find cancer cures for #youngpeople? Applications for our fully funded 4-year PhD programme starting in Autumn 2026 are open! bit.ly/4mHbPIH #uclcancer #QMBCI #KCLcancer_pharm #KCL #TheCrick

FAREWELL! After 6 month of Master research, Francesco B. Ciriscioli is returning to his home university in Triest, Italy. Thank you, Francesco, for your interesting results and for having enriched our group with your kind personality. We wish you all the best!

Great weather at daytime and northern lights at night time illuminate the scientific kick-off of the #HubMOL #MSCA doctoral network. On Someroy, a small island at the Artic Coast of Norway, we learn about the dual role of molecules such as NAD and SAM in signalling and metabolism.

MEET THE LAB! During the next 3 days, I am in northern Norway at the kick-off workshop of the HubMOL consortium. This MSCA doctoral network coordinated by Ines Heiland, University of Tromsø, aims to gain a better understanding of the dual role of NAD, CoA and co. in metabolism and signalling.

What a great first day at the GfG symposium on epigenetics & chromatin. Fantastic talks by @akispapantonis.bsky.social , @apombo1.bsky.social, @marcusbuschbeck.bsky.social and Philipp Korber. And Peter Becker giving the Max-Delbrueck lecture. A real treat for the audience!

Juri Kazakevych@juri-epigenomics.bsky.social · 11mo ago

Looking forward to exciting talks at the GfG Symposium in Gießen. Already found a poster, featuring my favourite gene: SMARCAD1, by Jacqueline Mermoud #epigenomics @diagenode.bsky.social @gfgenetik.bsky.social

NEW DOCTOR IN TOWN! Congratulations to Lejuan Shi from Sonia Forcales' lab who has defended her thesis today. As chair of her defense committee with Concepcio Soler and @tanyavavouri.bsky.social, I had the opportunity to discuss with Lejuan about the role of lncRNAs in cancer.

NEW LAB MEMBER! We welcome ‪@florherbstein.bsky.social who is joining us as a‬ ‪@carrerasleaders.bsky.social‬ Postdoctoral Fellow. She is alumni of #IBioBA-MPSP and the University of Buenos Aires.‬‬ She will study how nuclear metabolism influences proliferation and therapy resistance in AML.

Last 10 days to apply for this PhD position in medicinal chemistry!

Marcus Buschbeck and Lab@marcusbuschbeck.bsky.social · last yr.

OPPORTUNITY for a CHEMIST to JOIN US Are you interested in: 👍 Computer-aided ligand design 👍 Organic synthesis 👍 Biomedicine 👍 Drug development 👍 A multidisciplinary team 👍 And a PhD in Barcelona Then check this out! rb.gy/nc3lf3

OPPORTUNITY for a CHEMIST to JOIN US Are you interested in: 👍 Computer-aided ligand design 👍 Organic synthesis 👍 Biomedicine 👍 Drug development 👍 A multidisciplinary team 👍 And a PhD in Barcelona Then check this out! rb.gy/nc3lf3

VAC_61_2025 - CHEMISTRY RESEARCH ASSISTANT IN TRAINING - Institut de Recerca contra la Leucèmia Josep Carreras

Join the Josep Carreras Leukaemia Research Institute and contribute to our mission of innovating and advancing the fight against leukaemia and other hematologic diseases.

rb.gy

'NEW' LAB MEMBER! Our 2022 technician trainee Julia Ledesma is back. Julia is using the summer break of her biology studies at the University of Barcelona to help us advancing our projects as auxiliary technician. Thanks a lot, Julia.

Poster presentations by professors and group leaders for politicians. Maybe something we scientists should do in every country to make sure our elected representatives know what we are aiming to do.

Dr. Lucky Tran@luckytran.com · last yr.

BREAKING: Scientists are staging a “science fair” in the lobby of a Congressional building to tell elected officials about the critical knowledge the US will lose because their research grants have been canceled.

BREAKING: Scientists are staging a “science fair” in the lobby of a Congressional building to tell elected officials about the critical knowledge the US will lose because their research grants have been canceled.

We wrote a review on Transposable Elements (TEs) and almost all aspects of TE silencing and their roles in biological processes & disease. www.nature.com/articles/s41...

Transcriptional and post-transcriptional regulation of transposable elements and their roles in development and disease - Nature Reviews Molecular Cell Biology

Transposable elements (TEs) comprise nearly half of the human genome. This Review discusses transcriptional and post-transcriptional mechanisms that repress TE activity, how TEs escape this suppressio...

nature.com